Borosil Scientific Limited (BOM:544184)
India · Delayed Price · Currency is INR 113.00
+6.40 (6.00%)
At close: Feb 3, 2026
Borosil Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 4,338 | 4,385 | 3,960 | 980.43 | 1,062 | 651.95 |
Other Revenue | - | - | 0.11 | 3.65 | 2.32 | 2.08 |
| 4,338 | 4,385 | 3,960 | 984.08 | 1,064 | 654.02 | |
Revenue Growth (YoY) | 2.49% | 10.73% | 302.40% | -7.54% | 62.73% | 33.32% |
Cost of Revenue | 1,653 | 1,639 | 1,469 | 444.72 | 473.04 | 291.11 |
Gross Profit | 2,685 | 2,746 | 2,491 | 539.37 | 591.27 | 362.91 |
Selling, General & Admin | 869.24 | 840.18 | 794.6 | 138.03 | 131.93 | 99.88 |
Other Operating Expenses | 1,415 | 1,374 | 1,228 | 305.91 | 288.93 | 192.22 |
Operating Expenses | 2,474 | 2,399 | 2,187 | 514.58 | 482.58 | 344.15 |
Operating Income | 210.96 | 347.09 | 304.25 | 24.79 | 108.7 | 18.76 |
Interest Expense | -14.03 | -15.46 | -27.02 | -3.28 | -3.12 | -6.33 |
Interest & Investment Income | 39.59 | 39.59 | 24.65 | 0.74 | 0.37 | 0.71 |
Currency Exchange Gain (Loss) | 2 | 2 | 5.41 | 1.07 | 2.16 | 0.3 |
Other Non Operating Income (Expenses) | 47.53 | 30.5 | 6.49 | 3.54 | 4.55 | 1.42 |
EBT Excluding Unusual Items | 286.05 | 403.73 | 313.78 | 26.86 | 112.66 | 14.85 |
Gain (Loss) on Sale of Investments | 1.62 | 1.62 | 2.45 | 3.06 | 0.55 | - |
Gain (Loss) on Sale of Assets | -1.43 | -1.43 | -0.72 | -0.18 | - | - |
Pretax Income | 220.1 | 403.91 | 315.51 | 29.74 | 113.2 | 14.85 |
Income Tax Expense | 104.77 | 136.68 | 80.7 | 9.1 | 27.53 | 2.58 |
Earnings From Continuing Operations | 115.34 | 267.23 | 234.82 | 20.64 | 85.68 | 12.27 |
Minority Interest in Earnings | 1.68 | 0.81 | 0.77 | - | - | - |
Net Income | 117.02 | 268.04 | 235.59 | 20.64 | 85.68 | 12.27 |
Net Income to Common | 117.02 | 268.04 | 235.59 | 20.64 | 85.68 | 12.27 |
Net Income Growth | -59.46% | 13.78% | 1041.24% | -75.91% | 598.02% | - |
Shares Outstanding (Basic) | 90 | 89 | 89 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 90 | 89 | 89 | 2 | 1 | 1 |
Shares Change (YoY) | 1.42% | 0.13% | 5334.22% | 12.33% | 4.08% | 10.19% |
EPS (Basic) | 1.30 | 3.02 | 2.65 | 12.64 | 58.94 | 8.79 |
EPS (Diluted) | 1.30 | 3.02 | 2.65 | 12.64 | 58.94 | 8.79 |
EPS Growth | -59.97% | 13.84% | -79.03% | -78.55% | 570.67% | - |
Free Cash Flow | 1,044 | 1,059 | 171.27 | -223.9 | -39.44 | 12.17 |
Free Cash Flow Per Share | 11.61 | 11.91 | 1.93 | -137.11 | -27.13 | 8.71 |
Gross Margin | 61.90% | 62.63% | 62.91% | 54.81% | 55.55% | 55.49% |
Operating Margin | 4.86% | 7.92% | 7.68% | 2.52% | 10.21% | 2.87% |
Profit Margin | 2.70% | 6.11% | 5.95% | 2.10% | 8.05% | 1.88% |
Free Cash Flow Margin | 24.07% | 24.14% | 4.32% | -22.75% | -3.71% | 1.86% |
EBITDA | 384.48 | 515.64 | 452.46 | 95.43 | 170.4 | 70.75 |
EBITDA Margin | 8.86% | 11.76% | 11.43% | 9.70% | 16.01% | 10.82% |
D&A For EBITDA | 173.53 | 168.55 | 148.21 | 70.64 | 61.71 | 51.99 |
EBIT | 210.96 | 347.09 | 304.25 | 24.79 | 108.7 | 18.76 |
EBIT Margin | 4.86% | 7.92% | 7.68% | 2.52% | 10.21% | 2.87% |
Effective Tax Rate | 47.60% | 33.84% | 25.58% | 30.58% | 24.32% | 17.35% |
Revenue as Reported | 4,433 | 4,463 | 4,000 | 992.49 | 1,072 | 657.45 |
Advertising Expenses | - | - | - | 5.19 | 2.82 | 0.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.